Key result
Computational modeling combined with experimental data highlights ion channel targets in Parkinson's disease.
Why the study?
Ion channel dysfunction significantly contributes to the pathophysiology of Parkinson's disease, but summarizing recent experimental advancements alongside mathematical modeling is needed to advance targeted therapeutic strategies.
Understanding and mathematically modeling ion channel dysregulation in Parkinson's disease opens new avenues for targeted neuroprotective therapies and precise channel-directed treatments.
Ion channel therapies for Parkinson's remain experimental; extends modeling frameworks but leaves open clinical translation.
Parkinson's disease is a progressive neurodegenerative disorder in which ion channel dysfunction significantly contributes to the pathophysiology. This review summarizes recent advancements in the altered functions of voltage-gated sodium, potassium, and calcium channels, together with ligand-gated channels, revealing how these abnormalities disrupt neuronal excitability, synaptic transmission, autophagy, and metal ion homeostasis. Complementary mathematical modeling, ranging from Hodgkin-Huxley-type simulations of neuronal electrical activity to large-scale network dynamics and data-driven integrative frameworks, successfully reproduces experimental observations and predicts disease progression. These combined experimental and computational insights facilitate the development of targeted therapeutic strategies, including ion channel modulators and neuroprotective agents. By identifying key mechanistic links and overcoming current limitations in model complexity and data integration, this work underscores the importance of multidisciplinary collaboration among neuroscience, pharmacology, and computational biology to advance precise, channel-directed treatments for Parkinson's disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a review in Parkinson's disease. Ion channel dysfunction significantly contributes to Parkinson's disease pathophysiology, and integrating experimental insights with computational modeling facilitates the development of targeted therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: